Research Associate 3

Approval was granted based on the petitioner's extensive publication record of 17 peer-reviewed articles in high-impact journals and a significant citation count of 403. He also demonstrated his expertise by conducting at least 30 peer reviews for scientific journals. Furthermore, his research received funding from prestigious agencies including the NIH and NSF, validating the merit and practical value of his work to national public health.

The approval was based on the petitioner's record of 5 peer-reviewed journal articles and 2 preprints in highly ranked journals. He demonstrated sustained acclaim through 54 citations, including a paper in the top 10% of its field, and 12 completed peer reviews for prestigious venues. Additionally, the petition showed major research funding and significant contributions to drug sensitivity prediction and robotic navigation.

The petition was approved based on a record of 35 peer-reviewed articles, 4 patents, and over 2,640 citations, indicating major significance in the field. The petitioner also demonstrated active participation as a peer reviewer for 22 manuscripts. Additionally, the work received prestigious funding from the European Union Marie Skłodowska-Curie Actions and the Scientific and Technological Research Council of Turkey.

The approval was based on the petitioner's significant scholarly output including 7 peer-reviewed articles in high-impact journals and a high citation count of 651. Additionally, the petitioner demonstrated expertise by conducting 23 peer reviews for various papers. His critical role as a Senior Data Scientist developing AI models for cancer diagnosis further supported the extraordinary ability claim.